Records containing: Membranoproliferative Glomerulonephritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-02An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
-
CLINICAL_TRIALS study record update · 2026-03-23Towards the Most Accurate Diagnosis and Monitoring of Complement-mediated Rare Kidney Diseases
-
CLINICAL_TRIALS study record update · 2026-03-23Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
-
CLINICAL_TRIALS study record update · 2025-11-06US Early Access Program for the Treatment of Patients With C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis With Pegcetacoplan
-
CLINICAL_TRIALS study record update · 2025-08-06A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-22Phase 2, Multicenter, Randomized, Open-label, Controlled, 2-arm Cross-over Study to Evaluate the Clinical Efficacy of a Renin Inhibitor, Aliskiren, Compared to an Angiotensin Converting Enzyme Inhibitor, Enalapril, in C3 Glomerulopathy
-
CLINICAL_TRIALS study record update · 2025-02-07An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN
-
CLINICAL_TRIALS study record update · 2023-10-04National Registry of Rare Kidney Diseases (RaDaR)
-
CLINICAL_TRIALS study record update · 2021-07-16Single-center Phase 2 Open-label Trial Evaluating Efficacy and Safety of Daratumumab in Treatment of Patients With Proliferative Glomerulonephritis With Monoclonal Immune Deposits and C3 Glomerulopathy Associated With Monoclonal Gammopathy
-
CLINICAL_TRIALS study record update · 2019-02-19Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
-
CLINICAL_TRIALS study record update · 2018-01-17EVALUATING THE MORPHOFUNCTIONAL EFFECTS OF ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: A PILOT, SINGLE ARM STUDY IN TEN PATIENTS WITH PERSISTENT HEAVY PROTEINURIA
-
CLINICAL_TRIALS study record update · 2017-06-16Effect of Rituximab in Treatment of Primary Membranoproliferative Glomerulonephritis